Price T Rowe Associates Inc F Star Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.41 - $6.74 $2.96 Million - $3.68 Million	-546,607 Reduced 89.66%	63,047 $323,000
Q2 2022 Aug 15, 2022	SELL	$2.18 - $6.39 $392,260 - $1.15 Million	-179,936 Reduced 22.79%	609,654 $3.82 Million
Q1 2022 May 16, 2022	SELL	$2.77 - $5.36 $189,758 - $367,186	-68,505 Reduced 7.98%	789,590 $2.8 Million
Q4 2021 Feb 14, 2022	BUY	$4.71 - $7.38 $163,498 - $256,181	34,713 Added 4.22%	858,095 $4.31 Million
Q3 2021 Nov 15, 2021	SELL	$5.2 - $8.42 $22,599 - $36,593	-4,346 Reduced 0.53%	823,382 $6.03 Million
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $5.44 Million - $8.86 Million	827,728 New	827,728 $7.11 Million

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.